Long-term Safety of BCX9930 in Participants With Paroxysmal Nocturnal Hemoglobinuria

NCT05741346 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

28

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Paroxysmal Nocturnal Hemoglobinuria

Interventions

DRUG: BCX9930

Sponsor

BioCryst Pharmaceuticals